New: Evolving the Heatmap: Dow Jones, Nasdaq 100, Russell 2000, and More

BioNTech SE

Contributing Author

Recent Articles by BioNTech SE

Sep-08	First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity BNTX GlobeNewswire
Aug-27	Pfizer and BioNTech's COMIRNATY Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19 BNTX GlobeNewswire
Aug-04	BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update BNTX GlobeNewswire
Jul-25	Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union BNTX GlobeNewswire
Jul-21	BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025 BNTX GlobeNewswire
Jul-17	BioNTech Announces Ryan Richardson to Step Down from the Management Board BNTX GlobeNewswire
Jun-12	BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer BNTX GlobeNewswire
Jun-02	BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types BNTX GlobeNewswire
May-27	BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting BNTX GlobeNewswire
May-05	BioNTech Announces First Quarter 2025 Financial Results and Corporate Update BNTX GlobeNewswire
May-05	BioNTech Announces Appointment of Ramon Zapata to Management Board as Chief Financial Officer BNTX GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.